table network network 2
demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only observational study
COVID-19 prophylaxis (excluding children)
Vaxzevria (AstraZeneca Oxford - ChAdOx1 nCoV-19) COV005 Burn ... Simpson ... AstraZeneca phase 3 US ... Scotland cohort ComFluCOV ... EPIPHARE ... Valim Bernal ... Sultan AstraZeneca Oxford pooled analysis ... Pottegard Bonelli Husby ... John Com-COV2 Kanokudom AstraZeneca phase 3 US ... Bernal Asano Clemens Folegatti Com-COV Nguyen Patone ChAdOx1 phase 3 ... Edward ... Hippisley-Cox Rearte

4 studies excluded by filtering options 2

4992 Candidate COVID-19 Vaccine (COV001), 2020 210excludedrisk of bias not avaialble
6444 Barrett, 2020 200excludedrisk of bias not avaialble
9070 Tobaiqy M, 2021 2320excludednot a RCTrisk of bias not avaialble
9376 Nanthapisal, 2022 210excludedrisk of bias not avaialble

 

- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy - Licence Creative Commons